7-140808351-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAA

Variant summary

Our verdict is . The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The NM_004333.6(BRAF):​c.609-292_609-290dupTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00321 in 199,008 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Likely benign (★). The gene BRAF is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0087 ( 11 hom., cov: 21)
Exomes 𝑓: 0.0017 ( 0 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.618

Publications

1 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • large congenital melanocytic nevus
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004333.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 7-140808351-C-CAAA is Benign according to our data. Variant chr7-140808351-C-CAAA is described in ClinVar as Likely_benign. ClinVar VariationId is 1199855.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00874 (368/42106) while in subpopulation AFR AF = 0.0252 (349/13848). AF 95% confidence interval is 0.023. There are 11 homozygotes in GnomAd4. There are 168 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High AC in GnomAd4 at 368 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.609-292_609-290dupTTT
intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.609-292_609-290dupTTT
intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.609-292_609-290dupTTT
intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.609-290_609-289insTTT
intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.609-290_609-289insTTT
intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.609-290_609-289insTTT
intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.00871
AC:
367
AN:
42120
Hom.:
11
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0251
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00369
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000316
Gnomad OTH
AF:
0.00185
GnomAD4 exome
AF:
0.00172
AC:
270
AN:
156902
Hom.:
0
Cov.:
0
AF XY:
0.00170
AC XY:
157
AN XY:
92258
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00299
AC:
9
AN:
3010
American (AMR)
AF:
0.00171
AC:
13
AN:
7596
Ashkenazi Jewish (ASJ)
AF:
0.00234
AC:
10
AN:
4280
East Asian (EAS)
AF:
0.00176
AC:
9
AN:
5104
South Asian (SAS)
AF:
0.00149
AC:
44
AN:
29620
European-Finnish (FIN)
AF:
0.00178
AC:
12
AN:
6728
Middle Eastern (MID)
AF:
0.00163
AC:
1
AN:
614
European-Non Finnish (NFE)
AF:
0.00176
AC:
163
AN:
92746
Other (OTH)
AF:
0.00125
AC:
9
AN:
7204
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.349
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00874
AC:
368
AN:
42106
Hom.:
11
Cov.:
21
AF XY:
0.00852
AC XY:
168
AN XY:
19716
show subpopulations
African (AFR)
AF:
0.0252
AC:
349
AN:
13848
American (AMR)
AF:
0.00369
AC:
12
AN:
3256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1250
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1268
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1356
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1270
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
94
European-Non Finnish (NFE)
AF:
0.000317
AC:
6
AN:
18956
Other (OTH)
AF:
0.00183
AC:
1
AN:
546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.590
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.